Display options
Cite
Ochola LA, Ng'wena GM, Noland GS, et al. The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya. J Glob Infect Dis. 2013;5(4):131-7doi: 10.4103/0974-777X.122001.
Ochola, L. A., Ng'wena, G. M., Noland, G. S., Ondigo, B. N., Ayodo, G., & John, C. C. (2013). The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya. Journal of global infectious diseases, 5(4), 131-7. https://doi.org/10.4103/0974-777X.122001
Ochola, Lyticia A, et al. "The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya." Journal of global infectious diseases vol. 5,4 (2013): 131-7. doi: https://doi.org/10.4103/0974-777X.122001
Ochola LA, Ng'wena GM, Noland GS, Ondigo BN, Ayodo G, John CC. The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya. J Glob Infect Dis. 2013 Oct;5(4):131-7. doi: 10.4103/0974-777X.122001. PMID: 24672173; PMCID: PMC3958981.
Copy Download .nbib Format: NLM
Share it on

J Glob Infect Dis. 2013 Oct;5(4):131-7. doi: 10.4103/0974-777X.122001.

The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya.

Journal of global infectious diseases

Lyticia A Ochola, Gideon M Ng'wena, Gregory S Noland, Bartholomew N Ondigo, George Ayodo, Chandy C John

Affiliations

  1. Department of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno University, Maseno ; Kenya Medical Research Institute, University of Minnesota Malaria Program, Kisumu, Kenya.
  2. Department of Medical Physiology, School of Medicine, Maseno University, Maseno, Kenya.
  3. Department of Pediatrics, University of Minnesota, Minneapolis, USA.
  4. Department of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno University, Maseno.
  5. Kenya Medical Research Institute, University of Minnesota Malaria Program, Kisumu, Kenya.

PMID: 24672173 PMCID: PMC3958981 DOI: 10.4103/0974-777X.122001

Abstract

BACKGROUND: MB2 is a novel Plasmodium falciparum antigen of unknown function expressed in pre-erythrocytic and blood stages of infection in the human host. Interferon-gamma (IFN-γ) and interleukin (IL)-10 responses to other P. falciparum antigens have been associated with protection from clinical malaria, but these responses have not been studied for MB2. The present study was undertaken to characterize IFN-γ and IL-10 responses to P. falciparum MB2 antigen in adults living in areas of differing malaria transmission in Western Kenya.

MATERIALS AND METHODS: Cytokine responses to two 9-mer MB2 peptides predicted to be human leukocyte antigen (HLA) class I restricted T-cell epitopes were measured by enzyme-linked immunosorbent assay (ELISA) (IFN-γ and IL-10) and enzyme-linked immunosorbent spot (ELISPOT) (IFN-γ) in adults (n = 228) in areas of unstable and stable malaria transmission. HLA class I restriction of responses was assessed in a sub-group of the study population.

RESULTS: IFN-γ and IL-10 responses to MB2 peptides by ELISA were observed in both sites with no significant difference in prevalence (IFN-γ, unstable transmission area, 18.8%, stable transmission area, 27.5%, P = 0.33; IL-10, unstable transmission area, 22.5%, stable transmission area, 25.0%, P = 0.78). Prevalence of IFN-γ responses by ELISPOT was also similar in both areas (unstable, 10.8%, stable, 10.9%, P = 0.98). Neither IFN-γ nor IL-10 responses showed evidence of HLA class I restriction.

CONCLUSIONS: MB2 induces IFN-γ and IL-10 responses in adults living in both stable and unstable malaria transmission areas. Future studies should assess if these responses are associated with protection from clinical malaria.

Keywords: Enzyme-linked immunosorbent assay; Enzyme-linked immunosorbent spot; Human leukocyte antigen; Interferon-gamma; Interleukin-10; MB2; Malaria; Plasmodium falciparum

References

  1. Infect Immun. 2004 Sep;72(9):5135-42 - PubMed
  2. Infect Immun. 1999 Jul;67(7):3424-9 - PubMed
  3. Malar J. 2003 Nov 5;2(1):37 - PubMed
  4. PLoS One. 2009 Jul 31;4(7):e6465 - PubMed
  5. Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):10-7 - PubMed
  6. Trans R Soc Trop Med Hyg. 2005 Oct;99(10):780-6 - PubMed
  7. J Infect Dis. 2009 Aug 1;200(3):329-36 - PubMed
  8. Am J Trop Med Hyg. 2009 Sep;81(3):489-95 - PubMed
  9. Annu Rev Immunol. 2001;19:683-765 - PubMed
  10. J Infect Dis. 1999 Apr;179(4):980-8 - PubMed
  11. Infect Immun. 2005 Sep;73(9):5799-808 - PubMed
  12. J Med Entomol. 1990 Jul;27(4):570-7 - PubMed
  13. Am J Trop Med Hyg. 2006 Apr;74(4):585-90 - PubMed
  14. Clin Diagn Lab Immunol. 2002 Mar;9(2):348-51 - PubMed
  15. Malar J. 2009 Oct 23;8:235 - PubMed
  16. J Infect Dis. 1999 Jan;179(1):279-82 - PubMed
  17. J Immunol. 1999 Jul 15;163(2):884-92 - PubMed
  18. Nat Med. 2004 Apr;10(4):406-10 - PubMed
  19. Lancet. 1998 Jun 13;351(9118):1768-72 - PubMed
  20. Med Microbiol Immunol. 2001 Apr;189(3):115-26 - PubMed
  21. Clin Exp Immunol. 2000 Oct;122(1):94-100 - PubMed
  22. PLoS One. 2008 Apr 30;3(4):e2027 - PubMed
  23. J Biol Chem. 2001 Jul 13;276(28):26724-31 - PubMed
  24. Infect Immun. 1997 Dec;65(12):5082-7 - PubMed
  25. Am J Trop Med Hyg. 1999 Sep;61(3):488-94 - PubMed
  26. Infect Immun. 2000 Sep;68(9):5198-204 - PubMed
  27. N Engl J Med. 2011 Nov 17;365(20):1863-75 - PubMed
  28. Infect Immun. 1990 Sep;58(9):2989-94 - PubMed
  29. Tissue Antigens. 2004 Apr;63(4):293-325 - PubMed
  30. Infect Immun. 2009 Oct;77(10):4502-9 - PubMed
  31. J Immunol. 2008 Jan 1;180(1):444-53 - PubMed
  32. J Immunol. 2003 Dec 15;171(12):6961-7 - PubMed
  33. PLoS One. 2011;6(10):e25786 - PubMed
  34. Am J Trop Med Hyg. 2003 Apr;68(4):421-30 - PubMed
  35. Mol Biol Evol. 1999 May;16(5):627-33 - PubMed
  36. J Infect Dis. 1998 Aug;178(2):520-5 - PubMed
  37. Am J Trop Med Hyg. 2012 Nov;87(5):806-12 - PubMed

Publication Types

Grant support